Oct 15, 2023
Personalized PSA levels could improve prostate cancer screening
Posted by Shubham Ghosh Roy in categories: biotech/medical, genetics
The most common screening test for prostate cancer — a measure of prostate-specific antigen, or PSA, levels — so often suggests cancer where there is none that clinical guidelines no longer recommend the test for men over 70 and leave the decision up to younger patients.
Scientists at Stanford Medicine and their collaborators aim to make PSA screening more accurate — by calibrating PSA levels to each man’s genetics. Applying this type of personalization could significantly reduce overdiagnosis and better predict aggressive disease. Their research was published June 1 in Nature Medicine.
Continue reading “Personalized PSA levels could improve prostate cancer screening” »